Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Medicover plans IPO to raise SEK2bn for expansion

Medicover, the Pan-East European corporate healthcare provider and lab group, plans to IPO to expand internationally, raising SEK2bn for expansion of its core business into Emerging Markets.
August 19, 2016

Interview: Fernando Echevarne Santamaria, managing director, Echevarne laboratories

Faced with falling prices and limited expansion opportunities, Spain’s largest independent lab group Echevarne laboratories is trying to find new ways to grow. We speak to Fernando Echevarne Santamaria, managing director of Echevarne Laboratories, on whether the group's strategy to vertically integrate is paying off.
August 18, 2016

SAR’s sale on hold for the summer

Sources claim that negotiations between PAI Partners and private equity houses G-Square and Palamon to buy Spain's elderly care market leader SARquavitae are "progressing well towards a deal, but have been put on hold until September". On another note, we hear that Higinio Raventós, founder and president of SAR until 2014, passed away this morning.
August 4, 2016

Who’d buy Cerba?

Next in line in the big European lab sell-off is the French reference lab Cerba Healthcare. Cerba has plenty of potential for the right match, but with risks piling up, the price of 12-13 times EBITDA quoted in the French press looks dear. We give our analysis.
August 2, 2016

Interview: Andrés Gutiérrez, CEO, Médica Santa Carmen

Mexican renal care cost-cutter Médica Santa Carmen has concluded a second round of investments to expand from four clinics to 20-25 by 2021. We speak to CEO Andrés Gutiérrez about partnerships, the Mexican market and reaching out to the undiagnosed lower classes.
July 29, 2016

Cerba set for autumn sale

French lab group Cerba will be sold by its private equity owner PAI Partners in the autumn, reports the French daily Les Echos. It could fetch up to 13 times EBITDA from either European PE buyers, Canadian pension funds or emerging market buyers, and Natixiis and JP Morgan are handling the sale process, it reports.
July 22, 2016

Lifebrain sells Swiss labs to Synlab

Austrian based lab consolidator, Lifebrain, has sold its Swiss labs to Synlab and will now focus entirely on the fragmented Italian market, says CEO Dr Michael Havel. Having bought 100 labs in the last 12 months, he claims to have 50 more in the pipeline, and expects EBITDA margins of 30% on sales of €135m by 2017.
July 15, 2016

Universal health coverage and private health care: Friends or foes?

Universal Health Coverage is now explicitly targeted by the third sustainable development goal set out by the United Nations. Increasingly, governments around the world want to offer it to their citizenry. Where the capacity will come from is less certain. In this report, Healthcare Nova asks experts at the forefront of UHC schemes from India to Mexico, where UHC is today and what role the private sector should play in extending healthcare access to the poor?
July 13, 2016

UK healthcare faces up to Brexit

The UK has voted to leave the EU unleashing economic and political turmoil that has taken the legs out from under Sterling, ignited press hysteria and will likely see the leaders of both major parties replaced. As always, the NHS was front and centre during the campaign. But concerns for healthcare more broadly, including the private sector, are numerous. We talk to investors, operators and advisors.
July 1, 2016
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us